but Novo Nordisk is trying to change that. The Danish drugmaker has reported the first phase 3 results with its new basal insulin product – insulin icodec – which backs up earlier data ...

Five beaver kits have been born in Cairngorms National Park for the second year in a row – after a 400-year hiatus. The kits have been captured on camera at two separate sites in the park ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal.